secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2022-06-30T23:59:59+00:00
Accession:  0001104659-22-076309
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa shareholders elect three Class I directors, ratify PwC, approve say-on-pay
--------------------------------------------------------------------------------

- Sanj K. Patel, Thomas R. Malley, Richard S. Levy elected as Class I directors with 33.3M, 31.5M, 34.4M votes for respectively.
- Ratification of PricewaterhouseCoopers as auditor for FY2022 approved: 45.3M for, 33k against, 27k abstained.
- Advisory say-on-pay proposal approved: 41.5M for, 333k against, 56.6k abstained; 3.45M broker non-votes.
- Annual meeting held June 29, 2022; quorum present with Class A and Class B shares voting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000110465922076309/0001104659-22-076309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000110465922076309/tm2220044d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-076309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer